近期發表論文：

1. Lin YT, Wang HC, Tsai MH, Su YY, Yang MY*, Chien CY*. Angiotensin II receptor blockers valsartan and losartan improve survival rate clinically and suppress tumor growth via apoptosis related to PI3K/AKT signaling in nasopharyngeal carcinoma. Cancer. 2021. Jan 6. doi: 10.1002/cncr.33391. Epub ahead of print. (SCI; I.F.: 5.742; Oncology: 47/244 = 19.26%)
2. Chang GH, Chou FF, Tsai MS, Tsai YT, Yang MY, Huang EI, Su HC, Hsu CM*. Real‑world evidence and optimization of vocal dysfunction in end‑stage renal disease patients with secondary hyperparathyroidism. Sci Rep. 2021. Jan 12;11(1):653. (SCI; IF: 3.998, Multidisciplinary Sciences: 15/71 = 23.94%)
3. Chen YL, Chuang JH, Wang HT, Chen HC, Liu WH, Yang MY*. Altered Expression of Circadian Clock Genes in Patients with Atrial Fibrillation Is Associated with Atrial High-Rate Episodes and Left Atrial Remodeling. Diagnostics. 2021. Jan 7; 11(1): E90. (SCI; IF: 3.110; Medicine, General & Internal: 39/165 = 23.64%)
4. Tsai YT, Tsai MS, Chang GH, Lee LA, Yang MY, Yang YH, Wu CY, Hsu CM*. Patient-Related Factors of Medialization Laryngoplasty with Autologous Thyroid Cartilage. Healthcare (Basel). 2020. Nov 30; 8(4): E521. (SCI; IF: 1.916; Health Care Sciences & Services: 62/102 = 60.78%)
5. Yang CH, Hwang CF*, Chuang JH, Lian WS, Wang FS, Huang EI, Yang MY*. Constant Light Dysregulates Cochlear Circadian Clock and Exacerbates Noise-Induced Hearing Loss. Int J Mol Sci. 2020. Oct; 21(20): 7535. (SCI; IF: 4.556; Biochemistry & Molecular Biology: 77/297 = 24.92%)
6. Hsu CM, Yang MY, Fang TJ, Wu CY, Tsai YT, Chang GH, Tsai MS*. Maximum and Minimum Phonatory Glottal Area before and after Treatment for Vocal Nodules. Healthcare. 2020. Sep; 8:326. (SCI; IF: 1.916; Health Care Sciences & Services: 62/102 = 60.78%)
7. Chen RF, Yang MY, Wang CJ, Wang CT, Kuo YR*. Proteomic Analysis of Peri-Wounding Tissue Expressions in Extracorporeal Shock Wave Enhanced Diabetic Wound Healing in a Streptozotocin-Induced Diabetes Model. Int J Mol Sci. 2020. Jul; 21 (15):5445. (SCI; IF: 4.556; Biochemistry & Molecular Biology: 77/297 = 24.92%)
8. Lin SH, Ho JC, Li SC, Cheng YW, Yang YC, Chen JF, Hsu CY, Nakano T, Wang FS, Yang MY, Lee CH*, Hsiao CC*. Upregulation of miR-941 in Circulating CD14+ Monocytes Enhances Osteoclast Activation via WNT16 Inhibition in Patients with Psoriatic Arthritis. Int J Mol Sci. 2020. Jun; 21 (12):4301. (SCI; IF: 4.556; Biochemistry & Molecular Biology: 77/297 = 24.92%)
9. Yang MY, Lin PW, Lin HC*, Lin PM, Chen IY, Friedman M, Hung CF, Salapatas AM, Lin MC, Lin SF. Alternations of Circadian Clock Genes Expression and Oscillation in Obstructive Sleep Apnea. J Clin Med. 2019. Oct; 8 (10). pii: E1634. (SCI; IF: 3.303; Medicine, General & Internal: 36/165 = 21.82%)
10. Chen RF, Chang CH, Wang CT, Yang MY, Wang CJ, Kuo YR. Modulation of VEGF and MAPK-related pathway involved in extracorporeal shockwave therapy accelerate diabetic wound healing. Wound Repair Regen. 2019. Jan; 27(1):69-79. (SCI; I.F.: 2.471; Surgery: 70/210 = 33.33%)
11. Lin YT, Wang HC, Chuang HC, Hsu YC, Yang MY*, Chien CY*. Pre-treatment with angiotensin-(1–7) inhibits tumor growth via autophagy by downregulating PI3K/Akt/mTOR signaling in human nasopharyngeal carcinoma xenografts. J Mol Med. 2018. Dec; 96(12): 1407-1418. (SCI; I.F.: 4.427; Medicine, Research & Experimental: 36/138 = 26.09%)
12. Hsu CM, Lin PM, Lin HC, Tsai YT, Tsai MS, Li SH, Wu CY, Yang YH, Lin SF*, Yang MY*. NVP-BEZ235 attenuated cell proliferation and migration in the squamous-cell carcinoma of oral cavities and p70S6K inhibition mimics its effect. Int J Mol Sci. 2018. Nov; 19(11). pii: E3546. (SCI; IF: 4.556; Biochemistry & Molecular Biology: 77/297 = 24.92%)
13. Tsai HJ, Jiaang WT, Shih NY, Fletcher JA, Lin MJ, Yang MY, Chen CT, Hsu TJ, Wu CC, Lin HY, Chen LT. BPR1J373, a novel multi-targeted kinase inhibitor, effectively suppresses the growth of gastrointestinal stromal tumor. Cancer Sci. 2018 Nov; 109(11):3591-3601. (SCI; I.F.: 4.966; Oncology: 63/244 = 26.64%)
14. Hsu CM, Lin PM, Tsai YT, Tsai MS, Tseng CH, Lin SF, Yang MY*. NVP-BEZ235, a dual PI3K-mTOR inhibitor, suppresses the growth of FaDu hypopharyngeal squamous cell carcinoma and has a synergistic effect with Cisplatin. Cell Death Discov. 2018 May 10; 4:57. (SCI; I.F.: 4.114; Cell Biology: 76/195 = 38.97%)
15. Hsu CM, Lin PM, Chang JG, Lin HC, SH Li, Lin SF*, Yang MY*. Upregulated SLC22A3 has a potential for improving survival of patients with head and neck squamous cell carcinoma receiving cisplatin treatment. Oncotarget. 2017. Sep 26; 8(43): 74348-74358. (2016 SCI; IF: 5.168; Oncology: 44/217 = 20.28%)
16. Yang MY, Hsiao HH, Liu YC, Hsu CM*, Lin SF*, Lin PM*. Phe354Leu polymorphism of LKB1 is a potential prognostic factor for cytogenetically normal acute myeloid leukemia. In Vivo. 2017.  Sep-Oct; 31(5):841-847. (SCI; I.F.: 1.609; Medicine, Research & Experimental: 110/138 = 79.71%)
17. Tsai MS, Yang MY, Chang GH, Tsai YT, Lin MH, Hsu CM*. Autologous thyroid cartilage graft implantation in medialization laryngoplasty: a modified approach for treating unilateral vocal fold paralysis. Sci Rep. 2017. Jul 6; 7(1):4790. (SCI; IF: 3.998, Multidisciplinary Sciences: 15/71 = 23.94%)
18. Lin YT, Wang HC, Hsu YC, Cho CL, Yang MY*, Chien CY*. Capsaicin induces autophagy and apoptosis in human nasopharyngeal carcinoma cells by downregulating the PI3K/AKT/mTOR pathway. Int J Mol Sci. 2017. Jun 23; 18(7): 1343. (SCI; IF: 4.556; Biochemistry & Molecular Biology: 77/297 = 24.92%)
19. Chang LS, Lo MH, Li SC, Yang MY*, Hsieh KS*, Kuo HC*. The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease. Oncotarget. 2017. Jan 10; 8(2):2044-2052. (2016 SCI; IF: 5.168; Oncology: 44/217 = 20.28%)
20. Yang MY*, Lin SF*. The role of circadian clock genes in leukemia. Transl Cancer Res. 2016. Aug; 5(S2): S196-S198. (SCI; IF: 0.986; Oncology: 235/244 = 96.31%)Hsu CM, Lin PM, Lin HC, Lai CC, Yang CH, Lin SF*, Yang MY*. Altered expression of imprinted genes in squamous cell carcinoma of the head and neck. Anticancer Res. 2016. May; 36(5): 2251-2258. (SCI; IF: 1.994; Oncology: 203/244 = 83.20%)